Image of PAXgene Blood ccfDNA Tube (CE-IVD) (768165)

PAXgene Blood ccfDNA Tube (CE-IVD)

The PreAnalytiX® PAXgene® Blood ccfDNA Tube (CE-IVD) is CE marked for In Vitro Diagnostic use according to the Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices (IVDR).

For collection of whole blood samples and stabilization of circulating cell-free DNA (ccfDNA) from plasma and gDNA from the nucleated cellular fraction

  • CE Marked for In Vitro Diagnostic (IVD) use
  • Single tube collection, stabilization, transport and storage
  • Formaldehyde-free, non-crosslinking stabilization of circulating, cell-free DNA (ccfDNA)
  • Stabilization of ccfDNA in plasma and genomic DNA (gDNA) in the nuclear cellular fraction for days at various temperatures facilitates transport and storage
  • Standardized preanalytical processing of samples
  • Barcode with tube ID, lot number and expiration date and unique serial number
  • The PAXgene Blood ccfDNA Tube (CE-IVD) with the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) and QIAGEN QIAsymphony instrument (CE-IVD) are all CE marked for In Vitro Diagnostic Use according to Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices

Feature

Specification

Tube size

16 x 100 mm

Blood draw volume

10 mL

Additive Volume

1.5 mL

Length of stabilization of whole blood

  • 2–37°C for up to 3 days
  • 2–30°C for up to 7 days
  • 2–25°C for up to 10 days

Do not store blood-filled tubes below 2°C.

ccfDNA stabilization in plasma in secondary tube 

  • 15–25°C for up to 3 days
  • 2–8°C for up to 7 days

Plasma can be stored frozen at −20 or −80°C for at least 1 year (long term study ongoing) and is robust against at least three freeze/thaw cycles. 

Stabilization of gDNA in nucleated cellular fraction post centrifugation

  • 15–25°C for up to 3 days
  • 2–8°C for up to 7 days

Nucleated cellular fraction can be stored frozen at −20 or −80°C for at least 1 year (long-term study ongoing) and is robust against at least three freeze/thaw cycles.

Closure type/color

Pearl white BD Hemogard/Blue stopper

Quantity

100 tubes/case

Tube shelf-life

15 months from date of manufacture

ccfDNA Isolation from plasma

Automated with the QIAsymphony PAXgene Blood ccfDNA Kit using the QIAsymphony® SP instrument (including primary tube handling).

Manual with the QIAGEN QIAamp® DSP Circulating Nucleic Acid Kit.

gDNA Isolation from nucleated cellular fraction or buffy coat

Automated with the QIAGEN QIAsymphony DSP DNA Mini and Midi Kits using the QIAsymphony SP instrument.

Manual with the QIAGEN QIAamp DSP DNA Blood Mini Kit.


Intended Use

The PAXgene Blood ccfDNA Tube (CE-IVD) is intended for the collection, storage, and transport of human venous whole blood and stabilization of DNA for preparation of circulating, cell-free DNA (ccfDNA) from plasma and genomic DNA (gDNA) from the nucleated cellular fraction.

Image of ccfDNA workflow from blood samples

The PAXgene Blood ccfDNA Tube (CE-IVD), the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD), and QIAGEN QIAsymphony instrument (CE-IVD) are all CE marked for In Vitro Diagnostic Use according to Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices.

Plasma generated from whole blood collected into PAXgene Blood ccfDNA Tubes (CE-IVD) can be used to process ccfDNA automated with the QIAsymphony PAXgene Blood ccfDNA Kit, or manually with the QIAamp DSP Circulating Nucleic Acid Kit. The nucleated cellular fraction or buffy coat remaining after removal of the plasma can be processed for gDNA automated with the QIAsymphony DSP DNA Mini and Midi Kits, or manually with the QIAamp DSP DNA Blood Mini Kit.

*Only when used in combination with products for In Vitro Diagnostic use.

Order information

Product

Catalog No.

Price

PAXgene Blood ccfDNA Tube (CE-IVD)

Various
 

Details

Performance

PAXgene Blood ccfDNA Tubes (CE-IVD) simplify the collection and processing of whole blood for subsequent purification of circulating, cell-free DNA (ccfDNA) from plasma and genomic DNA (gDNA) from the nucleated cellular fraction. The tube additive is non-crosslinking, free of formaldehyde-releasing substances and inhibits apoptosis.

Using PAXgene Blood ccfDNA Tubes (CE-IVD) for whole blood collection, storage and transport helps prevent the release of intracellular DNA into plasma (Figure 1).

Plasma generated from whole blood collected into PAXgene Blood ccfDNA Tubes (CE-IVD) can be used to process ccfDNA automated with the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) or manually with the QIAamp DSP Circulating Nucleic Acid Kit. The nucleated cellular fraction or buffy coat remaining after removal of the plasma can be processed for gDNA automated with the QIAsymphony DSP DNA Mini and Midi Kits, or manually with the QIAamp DSP DNA Blood Mini Kit (Figure 2).

ccfDNA yields from plasma processed from blood collected into PAXgene Blood ccfDNA Tubes (CE-IVD) extracted with the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) or the QIAamp DSP Circulating Nucleic Acid Kit are similar to plasma from EDTA tubes separated directly after blood draw (Figure 3). However, in contrast to unstabilized EDTA, blood drawn into PAXgene Blood ccfDNA Tubes have stable ccfDNA levels for up to 10 days at temperatures up to 25°C, 7 days at temperatures up to 30°C, or 3 days at temperatures up to 37°C (Note: Do not store blood-filled tubes below 2°C), because DNA release from cells lysing or apoptosis is inhibited (Figure 4) and ccfDNA is preserved (Figure 5).

Genomic DNA in the nucleated cellular fraction is preserved and can be isolated with high purity, yield, and integrity (Figure 6). Thus, blood samples can be transported and stored within the specified temperature and duration to process plasma later (see technical note ´Sample Transportation Study (Summer Profile)´).

Plasma and nucleated cellular fraction generated from whole blood collected into PAXgene Blood ccfDNA Tubes are stable at room temperature for at least 3 days, at refrigerated temperature for at least 7 days and can be stored for long-term frozen at -20°C or -80°C (for latest update see technical note ´Plasma and Nucleated Cellular Fraction Stability Study´).

Pre-analytical steps including handling, storage, processing and documentation of verification and validation studies of PAXgene Blood ccfDNA Tube were conducted in accordance with ISO 20186-2:2019 and ISO 20186-3:2019: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 2: Isolated genomic DNA and — Part 3: Isolated circulating cell free DNA from plasma.

Stabilization characteristics have been shown to be robust against elevated level of endogenous, potentially interfering substances, underfilling and inappropriate mixing (see technical note ´Tube Robustness Study´).

Both ccfDNA and gDNA yields are high-quality and are compatible for downstream analytical PCR assays, including user-validated methylation-based PCR, and next-generation sequencing (NGS) molecular test methods (Figure 7).

Principle

The PAXgene Blood ccfDNA Tube is intended for the collection, storage, and transport of human venous whole blood and stabilization of DNA for preparation of circulating, cell-free DNA (ccfDNA) from plasma and genomic DNA (gDNA) from the nucleated cellular fraction. The tube contains an additive that keeps blood from coagulating and inhibits apoptosis via a non-crosslinking formaldehyde-free stabilization solution. This helps prevent the release of intracellular DNA into the plasma and maintains constant ccfDNA levels during sample transport and storage before processing.

Procedure

(For details, see PAXgene Blood ccfDNA Tube (CE-IVD) Instructions for Use)

Blood is collected under a standard phlebotomy protocol into a closed, evacuated tube that contains a proprietary ccfDNA stabilization additive. Whole blood sample can be stored 10 days at temperatures up to 25°C, 7 days at temperatures up to 30°C, or 3 days at temperatures up to 37°C. Do not store blood-filled tubes below 2°C.

Centrifugation of blood collected into a PAXgene Blood ccfDNA Tube at room temperature (15–25°C) for 15 minutes at 1,600–3,000 × g leads to separation of plasma and nucleated cellular fraction. The cellular fraction includes a buffy coat, a leukocyte and platelet rich layer, and a red blood cell fraction. Plasma is removed after the first centrifugation into a secondary tube. For ccfDNA isolation, the plasma is centrifuged again for 10 minutes at 1,600–3,000 × g. As an alternative, after a first centrifugation for 15 minutes at 3,000 × g, the tube can be directly placed on the QIAsymphony SP instrument for automated ccfDNA extraction using the primary tube handling protocol of the QIAsymphony PAXgene Blood ccfDNA Kit (applies to 3,000× g only)(Figure 8).

After removal of the plasma, the remaining nucleated cellular fraction can be used to isolate gDNA.

Applications

ccfDNA purified from plasma generated from whole blood collected in PAXgene Blood ccfDNA Tubes (CE-IVD) and purified using the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) or QIAamp DSP Circulating NA Kit can be used in a wide range of downstream applications, such as:


PAXgene Blood ccfDNA Tube (CE-IVD) is for in vitro diagnostic use.

Image of CE-0123 mark
Whole blood was stored in EDTA tubes or PAXgene Blood ccfDNA Tubes (CE-IVD). ccfDNA was extracted from the plasma immediately following blood collection (Day 0) and after 7- or 10-days storage at 25°C. Eluate (1 µl) was analyzed using the Agilent High Sensitivity DNA Kit. After 7 days storage, plasma from EDTA tubes showed an increase in apoptotic gDNA fragments, whereas plasma from PAXgene Blood ccfDNA Tubes (CE-IVD) showed a ccfDNA profile comparable to day 0.

Figure 1. PAXgene Blood ccfDNA stabilization reagent helps prevent release of gDNA into plasma.

Whole blood was stored in EDTA tubes or PAXgene Blood ccfDNA Tubes (CE-IVD). ...
PAXgene Blood ccfDNA Tube (CE-IVD) and QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) are CE Marked for In Vitro Diagnostic use according to EU Regulation on in vitro diagnostic medical devices (REGULATION (EU) 2017/746). Plasma generated from whole blood collected into PAXgene Blood ccfDNA Tubes (CE-IVD) can undergo automated ccfDNA extraction using QIAsymphony PAXgene Blood ccfDNA Kit, or manual processing with the QIAamp DSP Circulating Nucleic Acid Kit. The nucleated cellular fraction or buffy coat remaining after removal of the plasma can be processed for gDNA using either the QIAsymphony DSP DNA Mini and Midi Kits for automated extraction, or manually using the QIAamp DSP DNA Blood Mini Kit.
* Complete workflow CE-IVD only when used in combination with products for In Vitro Diagnostic use.

Figure 2. PAXgene Blood ccfDNA workflow (CE-IVD).

PAXgene Blood ccfDNA Tube (CE-IVD) and QIAsymphony PAXgene Blood ccfDNA Kit ...
Blood was drawn from consented, apparently healthy donors into EDTA or PAXgene Blood ccfDNA Tubes (CE-IVD). Plasma was processed from the tubes by centrifugation within 2 hours of blood collection. Manual ccfDNA purification was done for 120 blood donations for both PAXgene and EDTA with the QIAamp DSP Circulating Nucleic Acid Kit. Automated purification was performed for 200 blood donations from PAXgene Blood ccfDNA Tube plasma using the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) and from EDTA plasma using the QIAsymphony DSP Circulating DNA Kit on the QIAsymphony SP instrument. ccfDNA was analyzed for the 18S rDNA target gene. ccfDNA yield was calculated as the ratio of 18S rDNA copy numbers between ccfDNA from PAXgene relative to ccfDNA from corresponding EDTA tubes. Medians and the 25th and 75th percentiles are denoted.

Figure 3. Relative yield for ccfDNA from PAXgene Blood ccfDNA Tube (CE-IVD) plasma processed automated or manually compared to EDTA tube plasma at Day 0.

Blood was drawn from consented, apparently healthy donors into EDTA or PAXgene ...
Change in plasma ccfDNA yield after whole blood sample storage in comparison to plasma separated within 2 hours of blood collection (Day 0). Blood was drawn from consented, apparently healthy adult subjects and stored for 10 days at 25°C (n = 141), 7 days at 30°C (n = 261) and 3 days at 37°C (n = 144) followed by tube centrifugation and ccfDNA purification from plasma using the QIAsymphony PAXgene Blood ccfDNA Kit on the QIAsymphony SP instrument or the QIAamp DSP Circulating Nucleic Acid Kit. The relative ccfDNA yield was calculated as the ratio of the 18S rDNA copy numbers after sample storage compared to the copy numbers at Day 0. Medians and the 25th and 75th percentiles are denoted.

Figure 4. Minimization of DNA release into plasma from blood samples stored in the PAXgene Blood ccfDNA Tube (CE-IVD).

Change in plasma ccfDNA yield after whole blood sample storage in comparison to ...
Change in Y-chromosomal male plasma ccfDNA yield after whole blood sample storage in comparison to plasma separated within 2 hours of blood collection (Day 0). Blood was drawn from 10 male and 26 female consented, apparently healthy donors. Male blood was processed within 2 hours of blood collection and plasma was pooled. 500 µl of male plasma was added to each female 10 ml blood sample within 2 hours of blood collection. Whole blood samples were stored at various temperatures for the indicated number of days followed by tube centrifugation and ccfDNA purification from plasma using the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) on the QIAsymphony SP instrument. The relative ccfDNA yield was calculated as the ratio of the DYS14 copy numbers after sample storage compared to the copy numbers at Day 0. Medians and the 25th and 75th percentiles are denoted.

Figure 5. Preservation of ccfDNA yield in plasma from blood samples stored in the PAXgene Blood ccfDNA Tube CE-IVD).

Change in Y-chromosomal male plasma ccfDNA yield after whole blood sample storage ...
Blood was drawn from a donor pool of consented, apparently healthy adult subjects into PAXgene Blood ccfDNA Tubes (CE-IVD). The blood samples in each tube, 120 per storage condition, were stored at 25°C, 30°C or 37°C for the indicated number of days. Tubes were centrifuged, plasma was removed, and gDNA was extracted from 400 μl of nucleated cellular fraction. gDNA was purified using the QIAsymphony DSP DNA Mini Kit (elution volume: 400 μl) on the QIAsymphony SP instrument. 
Genomic DNA yield (A) and purity (B) were determined by spectrophotometry. For gDNA yield, medians and the 25th and 75th percentiles are denoted.  Genomic DNA integrity was determined by separation of 200 ng gDNA by agarose gel electrophoresis (C). A Lambda x Hind III marker was loaded into lane “M”. The upper band of this marker represents a DNA fragment of 23 kb. This representative image shows integrity of gDNA isolated from whole blood stored in the PAXgene Blood ccfDNA Tubes at 25°C for 10 days.

Figure 6. Yield, purity and integrity of gDNA from blood samples stored in the PAXgene Blood ccfDNA Tube CE-IVD).

Blood was drawn from a donor pool of consented, apparently healthy adult subjects ...
Blood from 60 healthy donors was stored in PAXgene Blood ccfDNA Tubes (CE-IVD) for 7 days at 25°C prior to ccfDNA extraction. NGS was performed on QIAGEN GeneReader system using the GeneRead QIAact Actionable Insights Tumor (AIT) panel (RUO). Sequencing data was analyzed with the QIAGEN Clinical Insight Analyze (QCI-A) tool for quality control (QC) parameters read coverage (A) and read quality (B). System QC thresholds for the most important NGS QC parameters (coverage 500x, coverage 200x and reads above average quality 25) define “passed” or “out-of-specification” samples. The AIT panel contains 773 variant positions in 12 genes.

Figure 7. Quality parameters demonstrate ccfDNA isolated from PAXgene Blood ccfDNA Tubes (CE-IVD) compatibility with NGS based test methods.

Blood from 60 healthy donors was stored in PAXgene Blood ccfDNA Tubes (CE-IVD) for ...
Blood was drawn from 21 consented, apparently healthy donors into multiple PAXgene Blood ccfDNA Tubes (CE-IVD). Within 4 hours of blood collection plasma was separated from the nucleated cellular fraction by a centrifugation of tubes for 15 minutes at 1,600 or 1,900 or 3,000 × g, followed by transfer of plasma into a secondary tube and a second centrifugation for 10 minutes at 1,600 or 1,900 or 3,000 × g (2x). In addition, one tube per donor was directly placed on the QIAsymphony SP Instrument after 3,000 x g (1x). 
ccfDNA was extracted with the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) on the QIAsymphony SP Instrument with plasma generated by a double centrifugation (2x) using the standard protocol for 2.4 ml (PAXcircDNA_2400 protocol) sample input and from plasma generated by a single centrifugation at 3,000 x g  using the 2.4 ml Primary Tube Handling Protocol (PAXcircDNA_PrimaryTube_2400 protocol). Each extraction from each plasma sample was done in duplicate. ccfDNA was analyzed for the 18S rDNA target gene. Copies of 18S rDNA target per mL plasma were based on a genomic DNA standard included into each PCR run. Box plots with medians, 25th and 75th percentiles and minimum to maximum are denoted; n = 42.

Figure 8. Impact of different plasma processing protocols on ccfDNA yield.

Blood was drawn from 21 consented, apparently healthy donors into multiple PAXgene ...

ccfDNA quality and stabilization chemistry -

browse here for our latest news, webinars and scientific posters.


Resources

Other Products Used in Conjunction


Need Help?

Product Information

For details about our products, reach out 
to our Global Contacts.

Technical Assistance

For troubleshooting or technical inquiries, 
get in touch with Technical Service.

Order Support

For help with placing or tracking an order, 
contact Customer Care.